Hamilton, HM -- (SBWIRE) -- 03/18/2013 -- PennyStockWatchMan.com is an investment community with a special focus on updating investors winning trading ideas, and issues Stock Alert on the stocks that run high. Today our focus is on following stocks, Kaleidoscope Venture Capital Inc (PINK:KLDO), Clean Coal Technologies Inc (PINK:CCTC), GRAN COLUMBIA GOLD (PINK:TPRFF), AMARANTUS BIOSCI INC (OTC:AMBS)
Kaleidoscope Venture Capital Inc (PINK:KLDO) jumped up +14.29% and closed at $0.0008. The 52-week range for the stock is $0.0001 and $0.0044 and during the previous trading session the stock touched its highest price at $0.0008. Its introductory price for the day was $0.0007, with the overall traded volume of 2.00 million shares. Kaleidoscope Venture Capital, Inc. operates as a multi-tiered communications and media holding company.
For How Long KLDO’s Gloss will Attract Investors? Find out via this report
Clean Coal Technologies Inc (PINK:CCTC), after opening its shares at the price of $0.06, jumped up +2.38% to close at $0.0560 for the day. The stock moved on a traded volume of 1.98 million shares, in comparison to 991,657.00 shares of average trading volume.
The 52-week range for the stock is $0.04 and $0.17 and during the previous trading session the stock touched its highest price at $0.06. Its introductory price for the day was $0.05. Clean Coal Technologies, Inc., a development stage company, owns a patented technology that uses controlled heat to extract and capture pollutants and moisture from low-rank coal.
Will CCTC Continue To Move Higher? Find Out Here
GRAN COLUMBIA GOLD (PINK:TPRFF) remained a bull for the day as it reported the upward momentum of +22.55% and closed at $0.250 after gaining total volume of 1.95 million shares. Its introductory price for the day was $0.21. So far, the company’s stock is up +20.19% in the three months period. In the last 6 months of trade it reported a decline of -39.76%. Gran Colombia Gold Corp. engages in the acquisition, exploration, and development of gold and silver in Colombia.
Why Should Investors Buy TPRFF After The Recent Gain? Just Go Here and Find Out
AMARANTUS BIOSCI INC (OTC:AMBS) reported the decline of -1.16% and closed at $ 0.0680 with the total traded volume of 1.94 million shares. The stock's opening price was $0.07. The company has a total market capitalization of $ 15.47 million.
The 52-week price range of the stock remained $0.01 - $0.20, while during last trade its minimum price was $0.06 and it gained its highest price of $0.07. Company's last 5 days shows down turn with a decline of -12.26%. Amarantus BioScience, Inc., a development-stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson’s disease, traumatic brain injury (TBI).
Will AMBS Get Buyers Even After The Recent Rally? Find Out Here
PennyStockWatchMan.com goal is simple: pick stocks poised to move explosively and present them to you. We dive in and out of promo/momo campaigns, play on disruptive news, sniff out unusual trading activity like insiders buying, and have a large network of traders, promoters and savvy players that give us a proprietary edge over any other penny stock site. Our edge is your edge. Go ahead and sign-up to our competitor’s alerts. When they fail, come back and see how we make money with penny stocks.
First things first – before viewing any of our information or subscribing to our alerts, you agree and fully understand that financial markets contain risk. That being said and agreed upon, if you directly or indirectly use the information on this website or this site’s newsletters or Press Release issued by us. You shall not hold PennyStockWatchman.com or any of its affiliates liable for any loss, injury, or damage resulting from the use of this website or newsletters emanating from this website.
Please read our full disclaimer at http://www.pennystockwatchman.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)